Systemically and topically active antinociceptive neurotensin compounds

Journal of Pharmacology and Experimental Therapeutics

Volumn 334, Issue 3, 2010, Pages 1075-1079

  Rossi, Grace C ^b   Matulonis, Joshua E ^a   Richelson, Elliott ^c   Barbut, Denise ^d   Pasternak, Gavril W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Department of Psychology CW Post Campus of Long Island University ^*  (United States)

^c MAYO CLINIC   (United States)

^d Sarentis Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(2S) 2 AMINO 3 (1H 4 INDOYL)PROPANOIC ACID; NEUROTENSIN DERIVATIVE; OPIATE; UNCLASSIFIED DRUG; ANALGESIC AGENT; NEUROTENSIN;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENCY; DRUG RESPONSE; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TAIL FLICK TEST; ANALOGS AND DERIVATIVES; ANIMAL; DIAGNOSTIC USE; DOSE RESPONSE; DRUG EFFECTS; HEAT; IMMERSION; INSTITUTE FOR CANCER RESEARCH MOUSE; PAIN MEASUREMENT; PATHOPHYSIOLOGY; REACTION TIME; STRUCTURE ACTIVITY RELATION; SUBCUTANEOUS DRUG ADMINISTRATION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANALGESICS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HOT TEMPERATURE; IMMERSION; INJECTIONS, SUBCUTANEOUS; MALE; MICE; MICE, INBRED ICR; NEUROTENSIN; PAIN MEASUREMENT; REACTION TIME; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77956252229     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.165282     Document Type: Article

References (30)

1. Bauco P and Rompré PP (2003) Differential sensitivity to neurotensin-induced hypothermia, but not analgesia, in Fischer and Lewis rats. Peptides 24:1189-1194.
2. Boules M, Fredrickson P, and Richelson E (2003) Current topics: brain penetrating neurotensin analog. Life Sci 73:2785-2792.
3. Boules M, Fredrickson P, and Richelson E (2006) Bioactive analogs of neurotensin: focus on CNS effects. Peptides 27:2523-2533.
4. Clineschmidt BV and McGuffin JC (1977) Neurotensin administered intracisternally inhibits responsiveness of mice to noxious stimuli. Eur J Pharmacol 46:395-396.
5. D'Amour FE and Smith DL (1941) A method for determining loss of pain sensation. J Pharmacol Exp Ther 72:74-79.
6. Dobner PR (2006) Neurotensin and pain modulation. Peptides 27:2405-2414.
7. Fang FG, Moreau JL, and Fields HL (1987) Dose-dependent antinociceptive action of neurotensin microinjected into the rostroventromedial medulla of the rat. Brain Res 420:171-174.
8. Fantegrossi WE, Ko MC, Woods JH, and Richelson E (2005) Antinociceptive, hypothermic, hypotensive, and reinforcing effects of a novel neurotensin receptor agonist, NT69L, in rhesus monkeys. Pharmacol Biochem Behav 80:341-349.
9. Fauq AH, Hong F, Cusack B, Tyler GM, Ping-Pang Y, and Richelson E (1998) Synthesis of (2S)-2-amino-3-(1H-4-indolyl)propanoic acid, a novel tryptophan analog for structural modification of bioactive peptides. Tetrahedron Asymmetry 9:4127-4134.
10. Katz LM, Wang Y, McMahon B, and Richelson E (2001) Neurotensin analog NT69L induces rapid and prolonged hypothermia after hypoxic ischemia. Acad Emerg Med 8:1115-1121.
11. Keegan KD, Woodruff GN, and Pinnock RD (1994) The pharmacology of neurotensin analogues on neurones in the rat substantia nigra, pars compacta in vitro. Eur J Pharmacol 253:131-137.
12. King M, Su W, Chang A, Zuckerman A, and Pasternak GW (2001) Transport of opioids from the brain to the periphery by P-glycoprotein: peripheral actions of central drugs. Nat Neurosci 4:268-274.
13. Kitabgi P, Carraway R, Van Rietschoten J, Granier C, Morgat JL, Menez A, Leeman S, and Freychet P (1977) Neurotensin: specific binding to synaptic membranes from rat brain. Proc Natl Acad Sci USA 74:1846-1850.
14. Kolesnikov Y, Jain S, Wilson R, and Pasternak GW (1996a) Peripheral kappa 1-opioid receptor-mediated analgesia in mice. Eur J Pharmacol 310:141-143.
15. Kolesnikov Y and Pasternak GW (1999a) Topical opioids in mice: analgesia and reversal of tolerance by a topical N-methyl-D-aspartate antagonist. J Pharmacol Exp Ther 290:247-252.
16. Kolesnikov YA, Chereshnev I, and Pasternak GW (2000) Analgesic synergy between topical lidocaine and topical opioids. J Pharmacol Exp Ther 295:546-551.
17. Kolesnikov YA, Jain S, Wilson R, and Pasternak GW (1996b) Peripheral morphine analgesia: synergy with central sites and a target of morphine tolerance. J Pharmacol Exp Ther 279:502-506.
18. Kolesnikov YA and Pasternak GW (1999b) Peripheral blockade of topical morphine tolerance by ketamine. Eur J Pharmacol 374:R1-R2.
19. Kolesnikov YA and Pasternak GW (1999c) Peripheral orphanin FQ/nociceptin analgesia in the mouse. Life Sci 64:2021-2028.
20. Kolesnikov YA, Pick CG, and Pasternak GW (1992) NG-nitro-L-arginine prevents morphine tolerance. Eur J Pharmacol 221:399-400.
21. Le Bars D, Gozariu M, and Cadden SW (2001) Animal models of nociception. Pharmacol Rev 53:597-652.
22. Ling GS and Pasternak GW (1983) Spinal and supraspinal opioid analgesia in the mouse: the role of subpopulations of opioid binding sites. Brain Res 271:152-156.
23. Ling GS, Spiegel K, Nishimura SL, and Pasternak GW (1983) Dissociation of morphine's analgesic and respiratory depressant actions. Eur J Pharmacol 86:487-488.
24. Maeno H, Yamada K, Santo-Yamada Y, Aoki K, Sun YJ, Sato E, Fukushima T, Ogura H, Araki T, Kamichi S, et al. (2004) Comparison of mice deficient in the high- or low-affinity neurotensin receptors, Ntsr1 or Ntsr2, reveals a novel function for Ntsr2 in thermal nociception. Brain Res 998:122-129.
25. Nemeroff CB, Osbahr AJ 3rd, Manberg PJ, Ervin GN, and Prange AJ Jr (1979) Alterations in nociception and body temperature after intracisternal administration of neurotensin, β-endorphin, other endogenous peptides, and morphine. Proc Natl Acad Sci USA 76:5368-5371.
26. Remaury A, Vita N, Gendreau S, Jung M, Arnone M, Poncelet M, Culouscou JM, Le Fur G, Soubrié P, Caput D, et al. (2002) Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not in analgesia. Brain Res 953:63-72.
27. Roussy G, Dansereau MA, Doré-Savard L, Belleville K, Beaudet N, Richelson E, and Sarret P (2008) Spinal NTS1 receptors regulate nociceptive signaling in a rat formalin tonic pain model. J Neurochem 105:1100-1114.
28. Tyler BM, Douglas CL, Fauq A, Pang YP, Stewart JA, Cusack B, McCormick DJ, and Richelson E (1999) In vitro binding and CNS effects of novel neurotensin agonists that cross the blood-brain barrier. Neuropharmacology 38:1027-1034.
29. Tyler-McMahon BM, Boules M, and Richelson E (2000a) Neurotensin: peptide for the next millennium. Regul Pept 93:125-136.
30. Tyler-McMahon BM, Stewart JA, Farinas F, McCormick DJ, and Richelson E (2000b) Highly potent neurotensin analog that causes hypothermia and antinociception. Eur J Pharmacol 390:107-111.